![Group of mountaineers](/media/hbmpartners/styles/hero_small/public/images/hero-images/hero-team.jpg?h=ffad0ca3&itok=6iZmDyBO)
Dr Emil Bujak
Advisor to HBM Partners
Over ten years of experience in venture capital and medicinal research. Prior experience as a registered pharmacist, and in antibody technology research at Philogen. Holds a PhD and an MSc in Medicinal and Industrial Pharmaceutical Sciences from ETH Zurich and is a Chartered Financial Analyst (CFA) since 2019. Board member of Polyneuron, board observer at Pyxis Oncology.
![Dr Emil Bujak](/media/hbmpartners/styles/team/public/images/team/bujak.jpg?h=a67c1a76&itok=E8mPMLdG)